Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» OphthaliX’s dry eye drug fails endpoint in Phase III study
OphthaliX’s dry eye drug fails endpoint in Phase III study
OphthaliX’s dry eye drug fails endpoint in Phase III study
Submitted by
admin
on December 30, 2013 - 12:10pm
Source:
Pharmaceutical Business Review
News Tags:
OphthaliX
dry eye disease
CF101
Headline:
OphthaliX’s dry eye drug fails endpoint in Phase III study
Do Not Allow Advertisers to Use My Personal information
